332 related articles for article (PubMed ID: 20438838)
21. Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms.
McLoughlin RM; Hurst SM; Nowell MA; Harris DA; Horiuchi S; Morgan LW; Wilkinson TS; Yamamoto N; Topley N; Jones SA
J Immunol; 2004 May; 172(9):5676-83. PubMed ID: 15100312
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of soluble IL-6 receptor concentration in serum and epithelial lining fluid from patients with interstitial lung diseases.
Yokoyama A; Kohno N; Hirasawa Y; Kondo K; Abe M; Inoue Y; Fujioka S; Fujino S; Ishida S; Hiwada K
Clin Exp Immunol; 1995 May; 100(2):325-9. PubMed ID: 7743672
[TBL] [Abstract][Full Text] [Related]
23. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa.
Karczewska-Kupczewska M; Adamska A; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
Clin Endocrinol (Oxf); 2013 Dec; 79(6):812-6. PubMed ID: 23199226
[TBL] [Abstract][Full Text] [Related]
24. Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation.
Bank U; Reinhold D; Schneemilch C; Kunz D; Synowitz HJ; Ansorge S
J Interferon Cytokine Res; 1999 Nov; 19(11):1277-87. PubMed ID: 10574621
[TBL] [Abstract][Full Text] [Related]
25. Release of interleukin-6 and its soluble receptors by activated peripheral blood monocytes is elevated in hypocholesterolemic hemodialysis patients.
Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Alevyzaki F; Zoga M; Kyritsis I; Ioannou D; Fatourou A; Nicolaou C
Am J Nephrol; 2005; 25(5):484-90. PubMed ID: 16127269
[TBL] [Abstract][Full Text] [Related]
26. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases.
Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D
Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965
[TBL] [Abstract][Full Text] [Related]
27. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis.
Montgomery ST; Dittrich AS; Garratt LW; Turkovic L; Frey DL; Stick SM; Mall MA; Kicic A;
J Cyst Fibros; 2018 Nov; 17(6):715-722. PubMed ID: 29884450
[TBL] [Abstract][Full Text] [Related]
29. C-reactive protein: a physiological activator of interleukin 6 receptor shedding.
Jones SA; Novick D; Horiuchi S; Yamamoto N; Szalai AJ; Fuller GM
J Exp Med; 1999 Feb; 189(3):599-604. PubMed ID: 9927522
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases.
Nikolaus S; Waetzig GH; Butzin S; Ziolkiewicz M; Al-Massad N; Thieme F; Lövgren U; Rasmussen BB; Reinheimer TM; Seegert D; Rosenstiel P; Szymczak S; Schreiber S
Int J Colorectal Dis; 2018 Jul; 33(7):927-936. PubMed ID: 29748708
[TBL] [Abstract][Full Text] [Related]
31. Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19.
Rodríguez-Hernández MÁ; Carneros D; Núñez-Núñez M; Coca R; Baena R; López-Ruiz GM; Cano-Serrano ME; Martínez-Tellería A; Fuentes-López A; Praena-Fernandez JM; Garbers C; Hernández-Quero J; García F; Rose-John S; Bustos M
Front Immunol; 2022; 13():891456. PubMed ID: 35634332
[TBL] [Abstract][Full Text] [Related]
32. Induction of interleukin-8 release by lung epithelium with cystic fibrosis epithelial lining fluid is marginally affected by inhibitors of interleukin-1beta.
Coulter KR; Allen ED; Hart J; Wewers MD; Castile RG; Knoell DL
Pharmacotherapy; 2000 Jan; 20(1):64-74. PubMed ID: 10641976
[TBL] [Abstract][Full Text] [Related]
33. The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases.
Garbers C; Monhasery N; Aparicio-Siegmund S; Lokau J; Baran P; Nowell MA; Jones SA; Rose-John S; Scheller J
Biochim Biophys Acta; 2014 Sep; 1842(9):1485-94. PubMed ID: 24878322
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor.
Garbers C; Thaiss W; Jones GW; Waetzig GH; Lorenzen I; Guilhot F; Lissilaa R; Ferlin WG; Grötzinger J; Jones SA; Rose-John S; Scheller J
J Biol Chem; 2011 Dec; 286(50):42959-70. PubMed ID: 21990364
[TBL] [Abstract][Full Text] [Related]
35. Enhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damage.
Jasiewicz M; Knapp M; Waszkiewicz E; Ptaszynska-Kopczynska K; Szpakowicz A; Sobkowicz B; Musial WJ; Kaminski KA
Cytokine; 2015 Dec; 76(2):187-192. PubMed ID: 26163998
[TBL] [Abstract][Full Text] [Related]
36. Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients.
Marie C; Losser MR; Fitting C; Kermarrec N; Payen D; Cavaillon JM
Am J Respir Crit Care Med; 1997 Nov; 156(5):1515-22. PubMed ID: 9372669
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of neutrophil dysfunction: neutrophil serine proteases cleave and inactivate the C5a receptor.
van den Berg CW; Tambourgi DV; Clark HW; Hoong SJ; Spiller OB; McGreal EP
J Immunol; 2014 Feb; 192(4):1787-95. PubMed ID: 24446515
[TBL] [Abstract][Full Text] [Related]
38. Role of soluble interleukin-6 receptor in inflamed gingiva for binding of interleukin-6 to gingival fibroblasts.
Naruishi K; Takashiba S; Chou HH; Arai H; Nishimura F; Murayama Y
J Periodontal Res; 1999 Aug; 34(6):296-300. PubMed ID: 10633884
[TBL] [Abstract][Full Text] [Related]
39. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
Rose-John S; Scheller J; Elson G; Jones SA
J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
